Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07637071 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study to Evaluate Xtressé Gummy Supplement in Men With Androgenic Alopecia

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Jan 2027 → Apr 2027
See other at-risk trials from Restore Biologics Holdings, Inc. dba Xtressé

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jun 22, 2026 to Sep 29, 2026v3 Show 6 more changesShow less
    • Primary completion pushed from Jan 2027 to Apr 2027
    • Enrollment increased: 40 → 48 participants
    • Study completion pushed from Mar 2027 to Jun 2027
    • Trial arms changed: 1 → 2
    • Interventions: Xtressé Hair Growth Gummies (Other) to Placebo Comparator (Dietary Supplement), Xtressé Hair Growth Gummies (Other)
    • Study description expanded, about 3 words
  2. Re-verified, no change to tracked fieldsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to determine if Xtresse' gummy is safe and may help regrow hair in men with androgenic alopecia (common pattern hair loss). Forty-eight participants will be randomly assigned to receive either Xtresse' active gummy or placebo. Neither staff not participant will know which treatment is given. The main aims of this trial are: 1. To confirm using photographic analysis, changes in the quality, volume, and thickness of hair. 2. To gauge patient satisfaction with hair changes and application process. 3. Monitor and report any adverse events associated with the daily intake of Xtressé Participants who qualify will complete 3 in-person visits. Participants will be given a 90-day supply of the gummies at visits 1 (after voluntary consent is given) and 2 to cover the 6-month study period. Photographs and scalp analysis will be performed at each visit to measure changes in hair volume, thickness, and growth.
Trial Details
NCT Number NCT07637071
Lead Sponsor Restore Biologics Holdings, Inc. dba Xtressé
Conditions
(from sponsor)		 Androgenic Alopecia, Hair Loss/Baldness, Hair Thinning
Related terms Alopecia
Enrollment 48 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov